Skip to main content

The keys to transforming metabolic health

GLP-1s: A new guide to cost, coverage, and care


From the Editors


The CVS Caremark Guide: Transforming Metabolic Health

The CVS Caremark Guide: Transforming Metabolic Health provides an overview of our customizable, integrated approach to GLP-1 management

Download the guide


Metabolic health has been in the spotlight as demand for glucagon-like peptide 1 receptor agonists, or GLP-1s, has grown. These medications have proven highly effective at treating type 2 diabetes and obesity, and recently gained approval to help reduce cardiovascular events. Additional indications are expected.

The efficacy of GLP-1s isn’t the only thing garnering national attention. They are also very expensive, which presents a challenge for plan sponsors. We developed The Caremark Guide: Transforming Metabolic Health to be a comprehensive reference for payors who want to provide coverage for clinically appropriate metabolic health therapies in a way that makes sense for their business.


The guide focuses on three keys that are crucial to optimal GLP-1 strategy:

  • Coverage – important considerations to inform your approach
  • Cost – utilization management strategies that can help rein in spend
  • Care – how personalized clinical and nutrition support can boost clinical efficacy and may even help some members avoid medication

It also links to additional resources, including:

We hope these resources can help inform your metabolic health strategy. To learn more about customizing an approach for your unique population, contact your account team for an opportunity analysis.


Learn more about GLP-1s

View our full collection of GLP-1 Insights articles to stay up to date with the latest information on this high-profile drug class.